Clinical

The benefits of animal-assisted therapy to human cancer patients have been widely observed anecdotally, but it’s been harder to demonstrate whether those interactions translate into measurable clinical outcomes. Now, a new study may be confirming that link.

The 2026 AAHA Diabetes Management Guidelines for Cats provide new guidance for feline patients with diabetes mellitus. This month we highlight an algorithm to help practitioners with management of hypoglycemia in diabetic cats.

The AAHA Referral Toolkit features actionable resources you can use to implement the concepts discussed in the 2025 AAHA Referral Guidelines.

Just a few days after halting pet dog exports to Mexico from the U.S. due to New World Screwworm cases, the USDA has now taken pet dogs off the list of animals barred from entering Mexico.

A recent new study of osteoarthritis in dogs highlights how often this condition goes undiagnosed, leading to potential missed opportunities to provide adequate pain management and optimize patient quality of life.

While there have been drugs to treat noise aversion and separation anxiety separately, this will be the first FDA-approved drug to do both.

Befrena is now the second injectable monoclonal antibody for the treatment of allergic dermatitis in dogs. Clinical studies report initial effectiveness within 24 hours of injection and itch relief that lasts six to eight weeks.

A recent report in JAAHA describes the first reported connection between ilunocitinib-induced bone marrow dyscrasia and the MDR1 mutation in dogs.

Continuous glucose monitors routinely used by human diabetic patients have now become commonplace in diabetes management for cats. But automated insulin delivery systems? Not so much. One pet parent decided to apply one to their diabetic cat anyway, and the cat has been in remission for two years. Learn more about how these systems work, challenges to their use in cats, and how one internist anticipates they will be utilized in the future.

The rise of veterinary hospice and end-of-life care represents a shift that both looks to the future and back to the profession’s roots by viewing this final stage as an opportunity to provide exceptional care, rather than a failure to heal. We’ve come a long way, and there’s incredible potential to continue evolving.